Delayed-onset psoriasiform eruption secondary to a phosphoinositide 3-kinase inhibitor: A case report and literature review

Duy C Tran; Maria Karim; Kristen Lo Sicco; Nooshin Brinster; Emily C Milam; Ian W Tattersall

doi:10.1016/j.jdcr.2022.02.043

Delayed-onset psoriasiform eruption secondary to a phosphoinositide 3-kinase inhibitor: A case report and literature review

JAAD Case Rep. 2022 Apr 1:24:97-100. doi: 10.1016/j.jdcr.2022.02.043. eCollection 2022 Jun.

Authors

Duy C Tran¹, Maria Karim², Kristen Lo Sicco¹, Nooshin Brinster³, Emily C Milam¹, Ian W Tattersall¹

Affiliations

¹ Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York.
² Hackensack Meridian School of Medicine, Nutley, New Jersey.
³ Bridge Dermpath, Tarrytown, New York.

No abstract available

Keywords: PI3K inhibitor; PI3K, phosphoinositide 3-kinase; PRP, pityriasis rubra pilaris; TCS, topical corticosteroid; TMP-SMX, trimethoprim/sulfamethoxazole; duvelisib; follicular lymphoma; phosphoinositide 3-kinase inhibitor; pityriasis rubra pilaris; psoriasiform; psoriasis.

Publication types

Case Reports